Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -173.00M
March 31, 2026 -175.66M
December 31, 2025 -184.76M
September 30, 2025 -235.19M
June 30, 2025 -250.84M
March 31, 2025 -284.40M
December 31, 2024 -239.86M
September 30, 2024 -254.07M
June 30, 2024 -280.80M
March 31, 2024 -280.82M
December 31, 2023 -324.98M
September 30, 2023 -337.00M
June 30, 2023 -337.36M
March 31, 2023 -355.28M
December 31, 2022 -309.46M
Date Value
September 30, 2022 -295.70M
June 30, 2022 -270.69M
March 31, 2022 -221.34M
December 31, 2021 -209.02M
September 30, 2021 -191.25M
June 30, 2021 -146.16M
March 31, 2021 -106.94M
December 31, 2020 -103.93M
September 30, 2020 -75.05M
June 30, 2020 -65.64M
March 31, 2020 -56.11M
December 31, 2019 -47.13M
September 30, 2019 -43.33M
June 30, 2019 -66.72M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Natera, Inc. 228.24M
Quest Diagnostics, Inc. 1.903B
Labcorp Holdings, Inc. 1.638B
OPKO Health, Inc. -123.38M
Psychemedics Corp. --